Suchergebnisse - V. P. Masenko
- Treffer 1 - 20 von 24
- Zur nächsten Seite
-
1
Rosuvastatin safety and efficacy in coronary heart disease patients von I. V. Sergienko, M. V. Ezhov, V. P. Masenko
Veröffentlicht 2006-10-01Aim. To study rosuvastatin safety and effects on lipid profile (LP) in coronary heart disease (CHD) patients. Material and methods. The study included 30 males (mean age 57±9 years) with diagnosed CHD, Functional Class II-III stable effort angina, receiving adequate basic therapy. In all participant...
Volltext
Artikel -
2
INHALED NITRIC OXIDE: CLINICAL EFFECTS AND INFLUENCE ON THE PROFILE OF INFLAMMATORY MARKERS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION von T. V. Martynyuk, S. N. Nakonechnikov, V. P. Masenko, I. E. Chazova
Veröffentlicht 2015-12-01Aim. To study the effect of treatment with inhaled nitric oxide (iNO) on the clinical status of patients with idiopathic pulmonary hypertension (IPH), and the profile of proinflammatory cytokines in peripheral blood. Material and methods. Patients with IPH (n=48) were included into the study. Evalua...
Volltext
Artikel -
3
Randomised study of ezetimibe, start doses of original statins, and their combination in patients with coronary heart disease and hyperlipidemia Part 2. Therapy effects on the leve... von A. V. Susekov, M. Yu. Zubareva, T. A. Rozhkova, V. P. Masenko
Veröffentlicht 2011-12-01Aim. To assess the effects of original statins as monotherapy or in combination with ezetimibe on the levels of proinflammatory cytokines and high-sensitive C-reactive protein (hsCRP) in patients with coronary heart disease (CHD) and hyperlipidemia (HLP). Material and methods. The study included 60...
Volltext
Artikel -
4
Adding cystatin C to the GRACE scale improves the prediction of bleeding complications in non-invasively treated patients with acute coronary syndrome von M. S. Kharchenko, A. D. Erlikh, E. I. Kosenkov, V. P. Masenko, N. A. Gratsianskyi
Veröffentlicht 2012-12-01Aim. To assess the prognostic performance of the GRACE scale extended by cystatin C levels in the prediction of ischemic and hemorrhagic in-hospital complications among patients with acute coronary syndrome (ACS). Material and methods. In 160 ACS patients, admitted to the Moscow City Clinical Hospit...
Volltext
Artikel -
5
Tissue myocardial Doppler echocardiography in the assessment of right ventricular function among patients with pulmonary hypertension of various aetiology von Yu. A. Andreeva, M. A. Saidova, T. V. Martynyuk, V. P. Masenko, I. E. Chazova
Veröffentlicht 2010-04-01Aim. To study right ventricular (RV) structure and function, assessed by standard echocardiography (EchoCG), tissue myocardial Doppler (TMD) EchoCG, and natriuretic peptide (NUP) levels, in patients with pulmonary hypertension (PH) of various aetiology. Material and methods. The study included 102 P...
Volltext
Artikel -
6
Fixed dose combination of perindopril with indapamide in primary prevention of cerebrovascular complications among patients with metabolic syndrome and arterial hypertension von V. B. Mychka, K. M. Mamyrbaeva, V. P. Masenko, V. B. Sergienko, I. E. Chazova
Veröffentlicht 2006-02-01Aim. To study 24-week Fixed dose combination of perindopril with indapamide (Noliprel®) therapy effects on parameters of 24-hour blood pressure monitoring (BPM), carbohydrate, lipid, and purine metabolism, tissue insulin sensitivity, and cerebral perfusion in patients with mild to moderate arterial...
Volltext
Artikel -
7
Cerebrovascular events primary prevention in metabolic syndrome patients von V. B. Mychka, K. M. Mamyrbaeva, V. B. Sergienko, V. P. Masenko, I. E. Chazova
Veröffentlicht 2006-04-01Aim. To study effects of therapy with bisoprolol (Concor®) and deproteinized hemoderivate (Actovegin®) on circadian blood pressure profile (CBPP), carbohydrate, lipid metabolism, and cerebral perfusion in patients with metabolic syndrome (MS) and mild arterial hypertension (AH). Material and methods...
Volltext
Artikel -
8
Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hyperte... von Yu. A. Andreeva, M. A. Saidova, T. V. Martynyuk, V. P. Masenko, S. N. Nakonechnikov, I. E. Chazova
Veröffentlicht 2008-12-01Aim. To study the associations between heart and pulmonary artery (PA) remodeling severity, according to echocardiography data, natriuretic peptide (NUP) levels, and renin-angiotensin-aldosterone system (RAAS) activation among patients with pulmonary hypertension (PH) of various etiology.Material an...
Volltext
Artikel -
9
CLINICAL AND HEMODYNAMIC PROFILE AND NEUROHORMONAL INDICATORS IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION, DEPENDING ON VASOREACTIVITY RESERVE OF PULMONARY ARTERIES von V. M. Paramonov, T. V. Martynyuk, Z. H. Dadacheva, N. M. Danilov, V. P. Masenko, I. Ye. Chazova
Veröffentlicht 2016-03-01Clinical and hemodynamic profile and neurohormonal indicators in patients with idiopathic pulmonary hypertension, depending on vasoreactivity reserve of pulmonary arteries. Objective: the main objective of our research work was an evaluation of clinical and hemodynamic profile, neurohormonal indicat...
Volltext
Artikel -
10
Perindopril metabolic effects and organo-protective action in metabolic syndrome patients von V. B. Mychka, V. P. Masenko, N. V. Flegontova, D. M. Ataullakhanova, V. B. Sergienko, I. E. Chazova
Veröffentlicht 2007-04-01Aim. To assess perindopril antihypertensive effects and its influence on metabolic disturbances, myocardial structure, and cerebral perfusion (CP) in patients with mild to moderate arterial hypertension (AH) and metabolic syndrome (MS) (AH + MS). Material and methods. Thirty patients with mild to mo...
Volltext
Artikel -
11
THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE von I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova
Veröffentlicht 2015-12-01Aim. To study the effect of treatment with metabolic corrector mildronate on lipid profile, inflammatory factors and endothelium function in patients with ischemic heart disease (IHD).Material and methods. 60 patients with IHD (stable exertional angina, II-IV functional class) were included in to th...
Volltext
Artikel -
12
RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE von T. G. Kulikova, O. V. Stepanova, M. P. Valihov, A. Yu. Shhedrina, A. N. Samko, V. P. Masenko, S. N. Tereshhenko
Veröffentlicht 2015-09-01Aim. To study content of resident progenitor cardiomyocytes in endomyocardial biopsy samples of patients with dilated cardiomyopathy (DCM) and heart failure (HF) at different disease stages and relate it to patient clinical characteristics.Material and methods. Resident progenitor cardiomyocytes wer...
Volltext
Artikel -
13
Myocardial revascularization effects on vascular endothelial growth factor and transforming growth factor β-1 in coronary heart disease patients von I. V. Sergienko, A. E. Semenova, V. P. Masenko, L. I. Habibullina, S. A. Gabrusenko, V. V. Kukharchuk, Yu. N. Belenkov
Veröffentlicht 2007-10-01Aim. To assess the dynamics of vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF- 1) and VEGF receptor Flt-1 (sFlt-1 or sVEGF-R1) levels in coronary heart disease (CHD) patients before and after myocardial revascularization. Material and methods: We examined fasting ser...
Volltext
Artikel -
14
Perspectives of impaired glucose tolerance management in patients with metabolic syndrome von K. P. Ivanov, V. B. Mychka, Yu. V. Zhernakova, E. V. Tishina, S. N. Tolstov, V. P. Masenko, I. E. Chazova
Veröffentlicht 2011-08-01Aim. To assess the effectiveness of vildagliptin, its effects on visceral obesity (VO), carbohydrate and lipid metabolism parameters, and circadian profile (CP) of blood pressure (BP) in patients with metabolic syndrome (MS), Stage I arterial hypertension (AH), and impaired glucose tolerance (IGT)....
Volltext
Artikel -
15
Skeletal Scintigraphy in Assesing the Response of Prostate Cancer Metastases to Androgen Deprivation Therapy von S. P. Mironov, E. I. Vasilenko, P. M. Cholak, V. P. Masenko, M. A. Shariya, D. V. Ustyuzhanin, V. B. Sergienko
Veröffentlicht 2021-09-01Androgen deprivation therapy (ADT) with luteinizing hormone-releasing hormone agonists is the basis for drug treatment in patients with metastatic prostate cancer (PC). An accurate assessment of the response of the tumor and its metastases is of primary importance for making a clinical decision rega...
Volltext
Artikel -
16
Vasoprotective statin effectiveness in patients with carotid atherosclerosis von Yu. B. Belousov, M. V. Leonova, E. P. Smirnova, N. V. Lyseyko, I. D. Stulin, V. P. Masenko, G. A. Tkachev
Veröffentlicht 2007-10-01Vasoprotective effectiveness of atorvastatin and clopidogrel was investigated in 29 patients with duplex scanning-verified carotid atherosclerosis. Clinical and instrumental examination included assessment of lipid profile, endothelial function, intima-media thickness, carotid atherosclerotic plaque...
Volltext
Artikel -
17
DIAGNOSIS AND TREATMENT OF MYOCARDITIDES von S. N. Tereshchenko, I. V. Zhirov, V. P. Masenko, O. Yu. Narusov, S. N. Nasonova, A. N. Samko, O. V. Stukalova, M. A. Shariya
Veröffentlicht 2019-09-01.
Volltext
Artikel -
18
Randomized «FARVATER» study. Atorvastatin (10 and 20 mg/d) in treating patients with coronary heart disease and dyslipidemia: effects on lipids, C-reactive protein and fibrinogen l... von A. V. Susekov, M. Yu. Zubareva, M. I. Tripoten’, T. A. Rozhkova, O. A. Pogorelova, T. V. Balakhonova, V. P. Masenko, V. V. Kukharchuk
Veröffentlicht 2006-12-01Aim. To compare effects of atorvastatin in the doses of 10 and 20 mg/d on lipid profile, C-reactive protein (hsCRP), fibrinogen levels, as well as vascular wall structure and function in patients with coronary heart disease (CHD) and primary hyperlipidemia (PHL). Material and methods. Fifty CHD and...
Volltext
Artikel -
19
Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospe... von A. G. Ovchinnikov, A. A. Borisov, K. Yu. Zherebchikova, O. Yu. Ryabtseva, A. D. Gvozdeva, V. P. Masenko, F. T. Ageev, S. A. Boytsov
Veröffentlicht 2021-02-01Aim. To assess the effect of the sodium-glucose transport protein 2 inhibitor empagliflozin on exercise tolerance and left ventricular (LV) diastolic function in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D).Material and methods. The present prospecti...
Volltext
Artikel -
20
IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE von M. V. Lediakhova, S. N. Nasonova, I. V. Zhirov, M. V. Andreevskaya, R. M. Bogieva, T. M. Uskach, M. A. Saidova, V. P. Masenko, S. N. Tereshchenko
Veröffentlicht 2018-05-01Background. Levosimendan infusion can be used in the treatment of patients with acute decompensated heart failure (ADHF) with a reduction in cardiac output and signs of severe congestion/pulmonary edema.Aim. To study impact of levosimendan on renal function in patients with ADHF with reduced systoli...
Volltext
Artikel